Evaluation of the concentration of malondialdehyde and nitrite in patients with sickle cell anemia treated or not with hydroxyurea

被引:0
|
作者
Dias Elias, Darcielle Bruna [1 ]
de Freitas, Rivelilson Mendes [2 ]
Goncalves, Romelia Pinheiro [3 ]
Ferreira Magalhaes, Hemerson Yuri [4 ]
de Sousa, Jacqueline Holanda [5 ]
Meira Magalhaes, Silvia Maria
机构
[1] Univ Fed Ceara UFC, Dev & Technol Innovat Drugs, Fortaleza, CE, Brazil
[2] Univ Fed Piaui UFPI, Teresina, PI, Brazil
[3] Univ Fed Ceara, Dept Univ Fed Ceara, Clin Analyses & Toxicol, Fortaleza, CE, Brazil
[4] Univ Fed Ceara, Hosp Univ Walter Cantideo, Fortaleza, CE, Brazil
[5] Univ Fed Ceara, Hosp Univ Walter Cantideo, Fortaleza, CE, Brazil
来源
EINSTEIN-SAO PAULO | 2010年 / 8卷 / 04期
关键词
Anemia; sickle cell/drug therapy; Malondialdehyde; Thiobarbituric acid reactive substances; Nitrite; Oxidative stress; Hydroxyurea/therapeutic use;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the serum levels of malondialdehyde and nitrite in patients with sickle cell anemia treated or not with hydroxyurea in outpatient's setting. Methods: Of the 65 patients with sickle cell anemia selected for the study, 51 were not treated with hydroxyurea (Group 1), 14 made chronic use of hydroxyurea (Group 2) and 20 individuals had no hemoglobinopathies (Control Group). Results: The Control Group had a lower and more homogeneous concentration of malondialdehyde levels as compared to the other groups. The results of Groups 1 and 2 showed increased values of malondialdehyde levels when compared to the Control Group. Considering the values of Groups 1 and 2, there were no significant changes in the malondialdehyde levels. There was no significant difference in the serum levels of nitrite between the groups. Group 2 presented a statistically significant correlation between serum malondialdehyde levels and the clinical variables investigated. In turn, Group 1 showed correlation only with occurrence of three or more vaso-occlusive crises. There was no correlation between nitrite levels and the clinical variables. Conclusion: The results revealed that during the pathogenesis of sickle cell anemia, an increase in lipid peroxidation was observed. On the other hand, no changes in oxidative parameters were detected during treatment with hydroxyurea, probably due to the short period of treatment of the patients studied.
引用
收藏
页码:414 / 418
页数:5
相关论文
共 50 条
  • [41] Effects of Hydroxyurea on Some Adhesion Molecules in Sickle Cell Anemia Patients
    Tarbiah, Nesrin
    Alhemadi, Maryam M.
    Almutairi, Huda S.
    Alamri, Reema S.
    Zaher, Galila F.
    Sabban, Alia M.
    Alkhattabi, Nuha A.
    INTERNATIONAL TRANSACTION JOURNAL OF ENGINEERING MANAGEMENT & APPLIED SCIENCES & TECHNOLOGIES, 2021, 12 (08):
  • [42] Hydroxyurea therapy in sickle cell anemia patients in Curacao, The Netherlands Antilles
    Saleh, AW
    Velvis, HJR
    Gu, LH
    Hillen, HFP
    Huisman, THJ
    ACTA HAEMATOLOGICA, 1997, 98 (03) : 125 - 129
  • [43] Hydroxyurea treatment in patients affected with sickle cell anemia: Efficacy and safety
    de Montalembert, M.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2008, 15 (1-2) : 34 - 38
  • [44] EARLY DETECTION OF RESPONSE TO HYDROXYUREA THERAPY IN PATIENTS WITH SICKLE CELL ANEMIA
    Ballas, Samir K.
    McCarthy, William F.
    Guo, Nan
    Brugnara, Carlo
    Kling, Gail
    Bauserman, Robert L.
    Waclawiw, Myron A.
    HEMOGLOBIN, 2010, 34 (05) : 424 - 429
  • [45] Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease
    Di Grazia, Daniela
    Mirabella, Cristina
    Chiara, Francesco
    Caudana, Maura
    Agar, Francesco Maximillian Anthony Shelton
    Zanatta, Marina
    Allegra, Sarah
    Bertello, Jenni
    Voi, Vincenzo
    Ferrero, Giovanni Battista
    Abbadessa, Giuliana
    De Francia, Silvia
    PHARMACEUTICALS, 2024, 17 (10)
  • [46] Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
    Moreira de Oliveira, Emanuel Almeida
    Boy, Kenia de Assis
    Pinho Santos, Ana Paula
    Machado, Carla da Silva
    Velloso-Rodrigues, Cibele
    Almeida Silva Gerheim, Pamela Souza
    Mendonca, Leonardo Meneghin
    EINSTEIN-SAO PAULO, 2019, 17 (04): : eAO4742
  • [47] Hydroxyurea: Why and how I use hydroxyurea to treat young patients with sickle cell anemia
    Pondarre, Corinne
    Soulie, Alizee
    HEMATOLOGIE, 2023, 29 (06): : 354 - 364
  • [49] Nitrite Levels Are Associated To Fetal Hemoglobin Concentration In Patients With Sickle Cell Anemia: Implications In Inflammatory Process
    Pitanga, Thassila Nogueira
    Cerqueira, Bruno A. V.
    Boas, Wendell Vilas
    Santana, Sanzio S.
    Reis, Joao O.
    Goncalves, Marilda Souza
    BLOOD, 2013, 122 (21)
  • [50] Evaluation of Markers of Intravascular Hemolysis and Endothelial Dysfunction in Sickle Cell Anemia Patients with and without Hydroxyurea Therapy
    Chenou, Francine
    Hounkpe, Bidossessi Wilfried
    Domingos, Igor de Farias
    Chaves Batista, Thais Helena
    Santana, Rodrigo Marcionilo
    Araujo, Aderson da Silva
    Cavalcanti Bezerra, Marcos Andre
    Costa, Fernando Ferreira
    Sonati, Maria de Fatima
    De Paula, Erich V.
    Nunes Santos, Magnun Nueldo
    BLOOD, 2019, 134